Sorry for your recent news,
May I ask, a little more info on the current condition. What percent of cancer in core samples?
If you have >1mm in sample size, you may want to have it tested (Oncotype DX) for type of cancer (nonaggressive vs aggressive) by gene markers. Your uro should be able to process the Oncotype DX test. A gene cancer type finding could provide added value to your treatment decision. If nonaggressive, why take aggressive treatment???
Others more knowledgably than me, will probably suggest that the low PSA (<10), Gleason 6 (3+3), cancer samples <50%, makes you a good candidate for AS. A good AS program will catch any cancer progression long before a "travel" condition takes place. You need to ask your uro these questions. He should explain "why" the aggressive treatment now. Seams a little early for aggressive treatment. You could have several years of AS (with no SE's) that would not increase your risk of future cancer treatment failure.
Access my AS story link in the below signature. You need to create a data history signature, so others fully understand your current condition to help.
________________________________________________________________________
OCTOBER 2015
Age: 59
PSA: 3.0 elevated to 3.5 in (6) months
3T-MRI: (1) lesion identified
Fusion Biopsy Results: Lesion cores benign, additional (12) cores = (1)5%
Pathology Summary: Grade Group 1 (GS6:3+3), 2nd pathology verification
Clinical Stage: T1c
Genetic DNA Profile: Above average risk for Aggressive PC (deCode Genetics)
Existing Cancer DNA Profile: DNA risk unknown (Oncotype DX test cannot be performed, <1mm)
High Grade Biological Score: 27% aggressive risk (Mi-Prostate Score)
Other Health Conditions: Diabetes Type II (DX 2000), on meds & insulin
PCa Treatment: "Active Surveillance"
Risk: Undetected Cancer Progression
Risk Likelihood: LOW
My Story: https://www.healingwell.com/community/default.aspx?f=35&m=3528051
Post Edited (NewDay) : 2/25/2016 8:55:15 AM (GMT-7)